H2C IN THE NEWS

ABOUT HAMMOND HANLON CAMP LLC

Hammond Hanlon Camp LLC (“H2C”) is an independent strategic advisory and investment banking firm committed to providing superior advice as a trusted advisor to healthcare organizations and related companies throughout the United States. H2C’s professionals have a long track record of success in healthcare mergers & acquisitions, capital markets, real estate, and restructuring transactions, acting as lead advisors on hundreds of transactions representing billions of dollars in value. Hammond Hanlon Camp LLC offers securities through its wholly-owned subsidiary H2C Securities Inc., member FINRA/SIPC. For more information, go to h2c.com

MEDIA CONTACT

Kelly T. Duong
Hammond Hanlon Camp LLC
858.242.4810

NEW YORK

623 Fifth Avenue
29th Floor
New York, NY 10022
212.257.4500

ATLANTA

3333 Piedmont Road
Suite 725
Atlanta, GA 30305
404.937.1350

CHICAGO

311 South Wacker Drive
Suite 5425
Chicago, IL 60606
312.508.4200

H2C News

SAN DIEGO

4655 Executive Drive

Suite 280
San Diego, CA 92121
858.242.4800

H2C Article on Health Tech Startup Investment Is a Cover Article for The Governance Institute

LATEST ARTICLES

H2C Wins HFMA Best Article Award

H2C Perspectives: Recession and Hospitals—It's Not How You Think

H2C Seller Strategies Series, Part 3: How Opportunity Zone Investing Can Offset the Impact of Tax Reform

H2C Seller Strategies, Part 2: Evaluating Opportunities for Capital Gains Tax Deferment

H2C Advises on the Sale of 3-Building Massachusetts Medical Office Portfolio

H2C M&A Sector Update • Competition for Healthcare IT Deals Remains High

Please reload

Hammond Hanlon Camp LLC (“H2C”) is pleased to share that Bill Hanlon’s article for The Governance Institute, featuring key considerations for healthcare leaders in determining whether direct investment in health tech startups is the right move, is the cover article for the Institute's "System Focus" newsletter.

Direct private investment by large health systems in healthcare services and technology companies is gaining traction, fueled by new competitors and innovations that are rapidly changing traditional business models. Today, more than 40 health systems have launched direct private investment initiatives or are participating in funds created by others.

In his article, “Disruption through Innovation: How Health Systems Are Becoming a New Class of Private Investor,” Hanlon, H2C Principal and Co-founder, provides insight on this trend from his work with large health systems that have made direct investments in healthcare services and technology companies. Hanlon also shares three questions health system board members and leaders should ask in evaluating the business case for investment in a health tech startup.

Read the article online (subscribers-only access). Care to continue the conversation? Email Bill for more information.

READ THE ARTICLE